Investments in digital healthcare spiked in 2021, but funding has since dropped dramatically.
Bill Taranto, president of Merck Global Health Innovation Fund, tells MobiHealthNews what interests Merck when it comes to investing in digital health and what health technology companies need to focus on to garner venture capital funds in 2023.
MobiHealthNews: What do you look for in a digital health...
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million.
WHAT THEY DO
PathAI’s platform employs convolutional neural...
Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield...
PatientSafe Solutions, the San Diego, California-based developer of the PatientTouch workflow-optimizing platform, announced that it has secured $25 million in its latest round of funding. Private investment firm HighBar Partners was the primary contributor, with additional capital coming from the Merck Global Health Innovation Fund, Camden Partners, Psilos Group, and TPG.
PatientTouch is a...
Doctor On Demand has hired Hill Ferguson, a former PayPal senior executive, as the company’s CEO. Ferguson will replace Doctor On Demand’s current CEO Adam Jackson. According to the press release, Jackson and the Doctor on Demand board decided the company needed a CEO with a different set of skills to grow its enterprise and direct to consumer businesses.
“Over the last three and a half years,...
Mountain View, California-based Livongo Health, the diabetes management company launched two years ago by former Allscripts CEO Glen Tullman, has raised $44.5 million from Merck Global Health Innovation Fund, Cowen Private Investments, Sapphire Ventures, Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, and Wanxiang America Corporation. This brings the company’s...
Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million.
Existing investors include Samsung Ventures, Merck Global Health...
Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners.
The company will use the funds to focus on growing adoption of its flagship offering, BlueStar, an FDA-cleared mobile...
Wesley Chapel, Florida-based care coordination platform CareSync raised $18 million in a round from the Merck Global Health Innovation Fund (Merck GHI), Greycroft Partners, and Harbert Venture Partners, with participation from existing investors Tullis Health Investors, Clearwell Group, CDH Solutions, and CareSync CEO Travis Bond. The company raised $4.25 million around this time last year.
“Our...
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
